Average Co-Inventor Count = 4.42
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Epizyme, Inc. (73 from 158 patents)
2. Ribon Therapeutics, Inc. (11 from 11 patents)
3. Eisai R&d Management Co., Ltd. (9 from 527 patents)
84 patents:
1. 12371421 - Solid forms of a PARP7 inhibitor
2. 12251386 - Salt form of a human histone methyltransferase EZH2 inhibitor
3. 12168016 - Aryl-OR heteroaryl-substituted benzene compounds
4. 12168015 - Aryl-or heteroaryl-substituted benzene compounds
5. 12161645 - Aryl-or heteroaryl-substituted benzene compounds
6. 11958837 - Quinazolinones as PARP14 inhibitors
7. 11691969 - Pyridazinones as PARP7 inhibtors
8. 11642348 - Substituted benzene compounds
9. 11633420 - Method of treating leukemia
10. 11566020 - Pyridazinones as PARP7 inhibitors
11. 11535621 - Heterobicyclic amides as inhibitors of CD38
12. 11491163 - Salt form of a human histone methyltransferase EZH2 inhibitor
13. 11370781 - Combination therapy for treating cancer
14. 11293927 - Screening methods for PARP modulators
15. 11052093 - Aryl-or heteroaryl-substituted benzene compounds